Current Roles

Employees:
102
Revenue:
$29.4M
About
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
Cara Therapeutics Address
107 Elm Street
Stamford, null
United States
Cara Therapeutics Email

Past Companies

Cara Therapeutics, Inc.CFO
American Biogenetic Sciences Inc.CFO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.